Podcasts about Fontan

On reçoit le casting du film “Le Marsupilami”, Philippe Lacheau, Tarek Boudali, Élodie Fontan, Julien Arruti, et Jamel Debbouze, en salle le 4 févrierLes vendredi et samedi à 20h sur France 5, Mohammed Bouhafsi et toute son équipe accueillent les personnalités qui font l'actualité.

On reçoit le casting du film “Le Marsupilami”, Philippe Lacheau, Tarek Boudali, Élodie Fontan, Julien Arruti, et Jamel Debbouze, en salle le 4 févrierLes vendredi et samedi à 20h sur France 5, Mohammed Bouhafsi et toute son équipe accueillent les personnalités qui font l'actualité.

On reçoit le casting du film “Le Marsupilami”, Philippe Lacheau, Tarek Boudali, Élodie Fontan, Julien Arruti, et Jamel Debbouze, en salle le 4 févrierLes vendredi et samedi à 20h sur France 5, Mohammed Bouhafsi et toute son équipe accueillent les personnalités qui font l'actualité.

Nos invités de la deuxième partie de C à Vous du samedi 7 février 2026: On reçoit le casting du film “Le Marsupilami”, Philippe Lacheau, Tarek Boudali, Élodie Fontan, Julien Arruti, et Jamel Debbouze, en salle le 4 févrierLes vendredi et samedi à 20h sur France 5, Mohammed Bouhafsi et toute son équipe accueillent les personnalités et artistes qui font l'actualité.

Laissez-vous tenter exceptionnel à trois jours de la sortie en salles du "Marsupilami" de Philippe Lacheau : Anthony Martin reçoit le réalisateur et une grande partie de l'équipe du film : Élodie Fontan, Tarek Boudali, Julien Arruti et Jamel Debbouze, grand spécialiste et protecteur du "Marsupilami"... Ecoutez Laissez-vous tenter avec Anthony Martin du 01 février 2026.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Nouvelle adaptation du héros de bande dessinée inventé par Franquin, petit animal taquin et rusé, jaune à taches noires, le "Marsupilami" de Philippe Lachau réunit évidemment la Bande à Fifi : Tarek Boudali, Élodie Fontan, Julien Arruti et Philippe Lacheau, mais aussi Jean Reno, Alban Ivanov, Reem Kherici, Gérard Jugnot et celui qui fait le lien avec le film d'Alain Chabat, Jamel Debbouze qui retrouve son personnage de Pablito, le défenseur du Marsu... Ecoutez Laissez-vous tenter avec Stéphane Boudsocq du 21 janvier 2026.Hébergé par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Švicarske oblasti so včeraj potrdile ugibanja prič požara v smučarskem letovišču Crans-Montana o najverjetnejšem vzroku nesreče. Ogenj naj bi zanetile iskre tortnih fontan, pritrjenih na steklenice šampanjca, ki so jih preveč približali stropu. Ta se je zaradi akustične izolacije hitro vnel. V nesreči je umrlo 40 ljudi, številni so v kritičnem stanju. Večina je mladih, starih od 16 do 26 let. Na prošnjo Švice po pomoči pri zdravljenju hudo opečenih se je odzvalo več evropskih držav, tudi Slovenija. V oddaji tudi: - Alpske smučarke bodo prvič v novem letu tekmovale v Kranjski Gori. - Jemenski separatisti napovedali referendum o neodvisnosti. - Kadrovsko pomankanje v vzgoji in izobraževanju se utegne letos še poglobiti.

This week we go back in time 2 years to review a recent paper from 2023 about outcomes of cardiac transplantation in the adult congenital heart patient (ACHD). Little has been written on this topic until this very robust and large scale report. How do single ventricle ACHD patients fair at transplant and how do they compare to non-ACHD heart transplant recipients? Why might 1 and 3 year outcomes not be a 'fair' method of assessing outcomes in this very high risk patient group? How do HLHS patient outcomes compare with other single ventricles? Are there better ways to measure risk in this patient group and how might the data in this work inform risk stratification and management of failing Fontan patients in whom transplantation is being considered? These are amongst the questions posed this week to the week's expert, Dr Daphne Hsu who is Professor of Pediatrics at the Albert Einstein College of Medicine at The Children's Hospital at Montefiore.https://doi.org/10.1016/j.jacc.2023.06.037For those interested in learning more about Dr. Hsu, take a listen to episode #166 from June, 2021:https://www.spreaker.com/episode/pediheart-podcast-166-a-conversation-with-professor-daphne-hsu--45144274

El duet catal

François, Jennifer, and Çınla discuss a few recent additions to the literature. If you are interested in reading the papers discussed in this episode, here they are (unfortunately, some may be behind paywalls): Freedom, State, and Market: The Real Worlds of Economic Planning Angus Hebenton and Martin O'Neill To Change or Not to Change. The Evolution of Forecasting Models at the Bank of England Aurélien Goutsmedt, Francesco Sergi, Béatrice Cherrier, Juan Acosta, Clément Fontan, and François Claveau Piero Sraffa and Counterfactuals: A View from Sraffa's Unpublished Papers in the Late 1920s Heinz D. Kurz, Neri Salvadori, and Rodolfo Signorino

This week we speak with Ohio State ACHD fellow Andrew Freddo MD, PhD about a recent large single center study he conducted assessing the cardiovascular drugs that adult Fontan patients are taking and whether they might offer us insights into general well-being. Are there agents that are associated with worse outcomes? If so, is this a situation of the agent causing harm or is it a possible marker of illness? Are there agents associated with improved outcomes? These are amongst the questions reviewed with Dr. Freddo this week. DOI: 10.1016/j.jacadv.2025.102070

This week we review an episode from 3 years back and delve into the world of adult congenital heart disease when we review a recent work from the ACHD team at UCSF that assesses the impact of BMI on clinical outcomes in the single ventricle adult Fontan patient. What is the cause of elevation in BMI in some Fontan patients? Is obesity the only explanation? Is BMI a modifiable risk factor for our Fontan patients and should exercise be 'prescribed' for these patients? If so prescribed, what type of exercise is best for the Fontan patient? This week's work's senior author, Dr. Anushree Agarwal, Assistant Professor of Medicine at UCSF, shares her insights into this important topic. DOI: 10.1161/JAHA.122.026732Also mentioned in today's episode is episode #222 with Dr. Dan Halpern of NYU medical center (https://www.stitcher.com/show/pediheartpediatric-cardiology-today/episode/pediheart-podcast-222-impact-of-cardiac-rehab-on-exercise-tolerance-in-the-achd-patient-206781483)

Send us a textSteven Hutchison has defied expectations his entire life. Born with hypoplastic left heart syndrome (HLHS) nearly four decades ago, he is now a 38-year-old husband, father of three, and full-time worker who approaches each day with remarkable perspective and gratitude.Diagnosed at two weeks old, Steven underwent staged surgeries including the Glenn and Fontan procedures, and now lives with Fontan-associated liver disease, one of the long-term complications that requires careful monitoring. But his story is about more than medical milestones. Steven shares how living on the same street as his parents and brother has created a strong support system, how he explains his condition to his children with honesty and hope, and how his faith and outlook shape the way he moves through life.From two 12-hour ablations to participating in groundbreaking research with HeartWorks, Steven's resilience continues to inspire. His message to parents of newly diagnosed HLHS babies is simple but powerful: there is so much more possibility today than when he was born.Steven's story is a reminder that people born with congenital heart disease can build meaningful lives filled with purpose, family, and joy—not despite their condition, but alongside it.Links to events mentioned in this episode:Link to register for FON-ONE: https://web.cvent.com/event/80f0addb-25c0-4d87-9cb1-99931b9062db/summaryCNOC Scientific Session: https://cardiacneuro.org/scientific-sessions/HeartWorks: https://heartworksinc.org/Support the showAnna's Buzzsprout Affiliate LinkBaby Blue Sound CollectiveSocial Media Pages:Apple PodcastsFacebookInstagramMeWeTwitterYouTubeWebsite

Send us a textTyler Šajdák wasn't supposed to grow up. Born with hypoplastic left heart syndrome in 1993, he was part of a generation receiving experimental surgeries with uncertain outcomes. Today, at 31, he works as an academic advisor, pursues a master's degree, and serves as a powerful advocate for the adult congenital heart defect community."I've been told by people that just by looking at me, they wouldn't know that I had a heart defect," Tyler shares during our conversation. This invisibility is both a blessing and a challenge for the growing population of adult CHD survivors who must navigate a healthcare system still learning how to treat them.Tyler's involvement with Single Ventricle One (SV1) - the recently unified organization combining pre-Fontan and post-Fontan networks - puts him at the forefront of efforts to improve care for adults with complex heart conditions. "I think my role is making sure the other planners are thinking of how the adults can be served as well," he explains, describing how medical conferences historically focused primarily on pediatric care.Our conversation delves into deeply personal territory as Tyler recounts his experience with vocal cord paralysis following surgery and the profound moment when his grandfather, after suffering a stroke, heard Tyler speak with a full voice for the first time shortly before passing away. We also discuss his recent transplant evaluation, where doctors delivered some surprising news.For anyone living with CHD or caring for someone with a heart defect, Tyler's story offers both practical guidance and emotional resonance. From balancing health concerns with career ambitions, to finding community with others who share similar experiences, he demonstrates how adults with congenital heart conditions can thrive while helping shape a medical field still discovering what lifelong care looks like for this first generation of survivors.Connect with the SV1 community through their upcoming patient day in Indianapolis this October - whether you're a patient seeking connection, a parent looking toward your child's future, or a medical professional committed to advancing care standards for this unique population.Helpful Links mentioned during this episode:Boston Children's Hospital Single Ventricle Family Day at the New England Aquarium: https://ow.ly/omax50WAN8AKristi Pena's episode about Barth Syndrome: https://www.buzzsprout.com/62761/episodes/398916Link to register for SV-One Fall 2025: https://www.svone.org/events/fall-The BriefAll your family's pressing concerns and questions, answered in one place. Mike...Listen on: Apple Podcasts SpotifySupport the showAnna's Buzzsprout Affiliate LinkBaby Blue Sound CollectiveSocial Media Pages:Apple PodcastsFacebookInstagramMeWeTwitterYouTubeWebsite

Mix of the Week #595 is "Spirit of Eden Mix Part I" by Stan Fontan Follow and include @tropical-traffic in your track ID requests Stan Fontan has been Djing and running discerning London club nights for over 30 years. A seasoned selector with a versatile style he's currently promotor of and resident at South London Disco Tropical Traffic. He was also the long term resident of Comeshakethewhole, spanning over 10 years as a residency at Cargo in Shoreditch. https://www.instagram.com/stanfontan/ -- ✉️ DC Email list: eepurl.com/dN23Jw

This week we review a recent important longitudinal follow up study of patients who have undergone palliation for the treatment of HLHS at The Children's Hospital of Philadelphia over the past 35+ years. What are the 'transplant-free' survival numbers at 35 years follow up following newborn palliation? Are there differences between hybrid and traditional "Norwood/Stage I" palliation? What factors explain the group of HLHS patients who do are 'super-Fontan's'? What accounts for the marked variability in outcomes of these complex patients? Dr. J. William Gaynor shares his deep insights both from his large scale paper and long-term experience caring for patients with HLHS.doi: 10.1016/j.jacc.2025.04.028

This week we venture back in time to 2023 to review the results of the update of the Single Ventricle Reconstruction trial, specifically SVR III. How are HLHS patients are faring post Norwood at age 12? What is the overall transplant-free survival rate in this group? Are there differences in survival seen at 12 years between BTTT shunt patients and RV-PA conduit shunt patients? How do they compare in exercise capabilities? What about rates of PLE or arrhythmias seen? Are there interventions that may improve outcomes going forward? These are amongst the questions reviewed this week with the first author, Dr. Caren Goldberg who is Professor of Pediatrics at the University of Michigan. DOI: https://doi.org/10.1161/circulationaha.123.065192

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Prevalence, Risk Factors, and Prognosis for Fontan-Associated Liver Disease: A Systematic Review and Exploratory Meta-Analysis.

Du lundi au vendredi, dans un podcast inédit, l'invité(e) du jour se confie au micro de RTL avant même son passage dans l'émission ! L'occasion d'en apprendre un peu plus sur lui, sur ses projets et sur ses souvenirs de l'émission "Les Grosses Têtes". Retrouvez tous les jours le meilleur des Grosses Têtes en podcast sur RTL.fr et l'application RTL. Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Face à Élodie Fontan, ce 6 mai 2025, Marc-Antoine Le Bret a notamment imité Emmanuel Macron, Gabriel Attal ou encore Jean-Luc Reichmann. Retrouvez tous les jours le meilleur des Grosses Têtes en podcast sur RTL.fr et l'application RTL.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Élodie Fontan, à l'affiche du film "Anges & Cie" est l'actrice de la semaine Ecoutez Laissez-vous tenter - Première avec Stéphane Boudsocq du 05 mai 2025.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Chaque samedi pendant une heure, la spécialiste cinéma d'Europe 1 Laurie Cholewa et ses chroniqueurs font le tour de l'actualité du septième art. Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Tous les jours dans Culture Médias, Thomas Isle dresse le portrait sonore de l'invité. Ce vendredi, c'est Romain Lancry et Élodie Fontan, pour le film "Anges et compagnie" dans les salles le 7 mai. Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Entouré de ses chroniqueurs et d'Anissa Haddadi, Thomas Isle reçoit celles et ceux qui font l'actualité culturelle et médiatique : dirigeants de chaînes, producteurs, animateurs, journalistes, chanteurs, acteurs, etc. Les auditeurs retrouvent "leurs indispensables" avec les signatures de la station. Une émission de 1h30 enrichie de débats autour des questions médiatiques, d'un jeu interactif et de nouvelles séquences donnant la parole aux auditeurs. Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

La comédie "Anges & Cie", réalisée par Vladimir Rodionov, débarque en salles mercredi 7 mai. Ecoutez L'invité de 9h40 avec Thomas Sotto et Céline Landreau du 01 mai 2025.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

La comédie "Anges & Cie", réalisée par Vladimir Rodionov, débarque en salles mercredi 7 mai. Ecoutez L'invité de 9h40 avec Thomas Sotto et Céline Landreau du 01 mai 2025.Distribué par Audiomeans. Visitez audiomeans.fr/politique-de-confidentialite pour plus d'informations.

Send us a textIn dieser speziellen deutschsprachigen Episode von 'Herz zu Herz mit Anna' spricht Jodi Alderfel mit Marina Lohri, die mit Trikuspidalatresie, ASD und VSD geboren wurde und eine modifizierte Fontan-Operation überlebte. Marina teilt ihre lebenslange Reise, von ihrer Herzoperation als Baby bis hin zu ihrer Karriere bei atHeart Medical, einem Unternehmen, das Geräte zur Behandlung von ASD entwickelt. Die Episode erörtert auch Marinas Erfahrungen mit Vorhofflimmern und einer Ablation im Jahr 2018. Marinas persönliche und berufliche Erfahrungen bieten wertvolle Einblicke für andere Patienten mit angeborenen Herzfehlern und zeigen, wie sie durch Mut und Entschlossenheit ein sinnvolles Leben führt.(Besonderer Dank geht an Jodi Alderfel, die uns in dieser Folge als Gastmoderatorin zur Seite stand.)In this special German-language episode of 'Heart to Heart with Anna,' Jodi Alderfel speaks with Marina Lohri, who was born with tricuspid atresia, ASD, and VSD and survived a modified Fontan procedure. Marina shares her lifelong journey, from her heart surgery as a baby to her career at atHeart Medical, a company developing devices to treat ASD. The episode also discusses Marina's experience with atrial fibrillation and an ablation in 2018. Marina's personal and professional experiences offer valuable insights for other patients with congenital heart disease and show how she leads a meaningful life through courage and determination.Here is a link to Marina's episode in English with Anna: https://tinyurl.com/Marina-LohriSheri Turner is our newest Defender Patron and she also serves as a HUG Volunteer. Thank you so much for your generosity and all you do, Sheri!Support the showAnna's Buzzsprout Affiliate LinkBaby Blue Sound CollectiveSocial Media Pages:Apple PodcastsFacebookInstagramMeWeTwitterYouTubeWebsite

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Increased Endothelin-1 Is Associated With Morbidity in Single Ventricle Heart Disease in Children Undergoing Fontan Palliation.

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Characteristics and Survival Outcomes of Hepatocellular Carcinoma After the Fontan Operation.

This week we review a study assessing the impact of bundle branch block (BBB) on exercise tolerance amongst the single ventricle Fontan patient cohort. Why would this be associated with worse outcomes for exercise? How should the cardiologist use this datum of BBB in a single ventricle patient to inform clinical decision making in this patient group? Why is cardiac resynchronization therapy so challenging in this patient group? Dr. Omar Meziab of The University of Arizona shares his deep insights this week. https://doi.org/10.1007/s00246-024-03500-1

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Acute Effects of Enhanced External Counterpulsation in Adults With Fontan Circulation.

A pediatric thoracic surgeon at Indiana University, has spent decades fixing broken hearts. And his research led him to a team of engineers at NASA.

This week we step back in time 3 years ago to review an important cardiac MRI report on Fontan geometry and hemodynamics as measured by computational fluid dynamic analysis. How do factors like Fontan geometry or 'power loss' relate to quality of life for the Fontan young adult patient? How do these data inform imaging in the operating room during these palliations? We speak with the first author of this work, Associate Professor of Pediatrics at U. Penn, Dr. Laura Mercer-Rosa about this important and intriguing work. https://doi.org/10.1016/j.athoracsur.2022.01.017

This week we review a recent large scale, multicenter adult congenital heart study on outcomes of HLHS Fontan patients versus other single RV Fontan patients. How do the two groups compare in regards to thromboembolic risk, risk for arrhythmia or risk for death and heart transplantation? Why might there be differences between these single RV patient groups? How can these results inform management? We speak with Assistant Professor of Medicine and Pediatrics at The Icahn School of Medicine at  Mount Sinai, ACHD expert Dr. Kali Hopkins. doi: 10.1161/JAHA.124.034757. Epub 2024 Nov 27

En este episodio: nos despedimos del sobreviviente Fermín Fontanés; lo último de la Extraordinaria; quién gana y quién pierde en el escrutinio y las movidas de la burócrata nivel sayayín Yanira Raíces para atornillarse en Educación. - ¡Vota AHORA en los PPP Awards en podcastppp.com! - Si fueras partes de nuestro patreon, hubieras escuchado este episodio ayer martes. ¡Únete a la mejor comunidad del internet boricua en patreon.com/puestospalproblema! Aprovheca la oferta de Cyber Week todo el mes de diciembre. - Presentado por el mejor internet de Puerto Rico - AeronetPR.com. Cambiate ahora llamando al 787 273 4143. Nuestros Patroncitos PYMES de hoy: High Quality Solutions es un equipo especializado en la impermeabilización de techos y pintura en PR. En el sellado de techo, nos enfocamos en preparar y reparar las superficies, utilizando materiales destinados para este uso y de alta calidad. Ofrecemos varios sistemas de sellado, como para techos regulares y/o transitables. Sistemas en Silicona y Poliuretanos, Cementicios y otros. LLEGAN AL TECHO ORIGINAL! LIMPIAN TODO ANTES DE PONER EL TRATAMIENTO. Nuestros sistemas son perfectos para residencias, comercios, terrazas, Airbnb, estacionamientos, cisternas, entre otros. Preparamos de forma efectiva ante cualquier inclemencia del tiempo, como lluvias, tormentas y huracanes. Evitar humedad y filtraciones, que afectan la calidad de vida. También realizamos trabajos de pintura, con productos de compañías prestigiosas. Mejoramos el aspecto estético, transformando el entorno en uno renovado. Nos encargamos de convertir la visión de nuestros clientes en realidad. En High Quality Solutions ofrece servicios que garantizan la durabilidad y seguridad de la inversión. Brindamos garantías para nuestros trabajos y estamos certificados por DACO, Seguro de Responsabilidad Pública y El Fondo de Seguro del Estado, para mantener la confianza de nuestros clientes. Pueden comunicarse con José R. Nieves Solís, contratista al 787-223-8960 o al cel.787-552- 4631. Puedes acceder a nuestra página hqsolutionspr.com, para más información. También puede buscarnos en Instagram y Facebook como High Quality Solutions. Bright International Investments ofrece servicios relacionados a las finanzas. Específicamente creamos y manejamos carteras de portafolios de inversión a clientes particulares que deseen invertir su dinero en la Bolsa de Valores de Nueva York. Tú haces la inversión y nosotros nos encargamos del resto. Este 2024 sácale dinero a tu dinero y hazte cargo de tu futuro. ¡Bright International Investments es tu solución! ¡Por un futuro brillante! Para más información visita brightinternationalinvestments.com. Suscríbete a nuestro Patreon y recibe contenido exclusivo, artículos: https://patreon.com/puestospalproblemaSee omnystudio.com/listener for privacy information.

In this episode, Dr. Valentin Fuster highlights five cutting-edge cardiology studies from the December 2024 issue of JACC, covering topics such as cardiac MRI's role in predicting sudden cardiac events in Fontan patients, the impact of oxidized phospholipids on calcific aortic valve disease, and the effects of renal and liver function on outcomes after tricuspid valve repair. With insights on mortality risks from influenza in heart failure patients and the outcomes of anatomical versus physiological repair for congenital heart defects, the episode offers a comprehensive look at critical advancements in cardiovascular care.

In this episode, Dr. Valentin Fuster discusses a groundbreaking study on cardiac MRI predictors of arrhythmic sudden cardiac events in patients with Fontan circulation, highlighting key risk factors for these life-threatening incidents. The study, part of the multi-center FORCE registry, reveals significant findings, including the impact of clinical status and ventricular function, while emphasizing the importance of large-scale research in improving outcomes for single ventricle patients.

This week we delve into the world of adult congenital heart disease to review the topic of liver disease in the Fontan patient and specifically, hepatocellular carcinoma (HCC). What is the prevalence of this disease in the Fontan single ventricle adult patient? How effective are scores like the MELD-XI or Fibrosis-4 Index at identification of HCC in the Fontan patient? How should the Fontan adult patient be surveilled for this form of cancer? What evidence is there that earlier identification of HCC is associated with better outcomes? What may prove to be the most important factor in protection of the liver in the Fontan patient? Dr. Yuli Kim, Director of the ACHD program at The University of Pennsylvania shares her deep insights this week into this important topic. DOI: 10.1093/eurheartj/ehad788

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances discusses a recently published original research paper on liver imaging in fontan patients, comparing ultrasound to cross-sectional imaging.

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning discusses the latest salaries and conditions of cardiothoracic surgeons in the United States. He explores the highest versus lowest compensation areas, areas with the highest growth for compensation, and where cardiothoracic surgeons rank among other surgeons. He also highlights the highest paid specialties, burnout rates, early retirement, and noncompete clauses.   Joel also reviews recent JANS articles on transcatheter aortic valve replacement for asymptomatic severe aortic stenosis, transcatheter aortic valve replacement in patients with systolic heart failure and moderate aortic stenosis, valve-in-valve transcatheter aortic valve replacement versus isolated redo surgical aortic valve replacement, and the seven pillars of techniques to treat and repair tricuspid endocarditis.  In addition, Joel explores surgical aortic annulus enlargement using a balloon technique, quadruple valve replacement for carcinoid heart disease, and Fontan conversion in a patient with hypoplastic left heart syndrome. Before closing, he highlights upcoming events in CT surgery. JANS Items Mentioned  1.) Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis—EARLY TAVR Trial  2.) Transcatheter Aortic Valve Replacement in Patients With Systolic Heart Failure and Moderate Aortic Stenosis: TAVR UNLOAD  3.) Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Isolated Redo Surgical Aortic Valve Replacement  4.) The Seven Pillars of Techniques to Treat and Repair Tricuspid Endocarditis  CTSNET Content Mentioned  1.) Surgical Aortic Annulus Enlargement Using a Balloon Technique  2.) Quadruple Valve Replacement for Carcinoid Heart Disease  3.) Fontan Conversion in a Patient With Hypoplastic Left Heart Syndrome: A 38-Year-Old Norwood Saga  Other Items Mentioned  1.) Doximity Pay Report 2023   2.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

Send us a textMeet Marina Lohri, a true trailblazer in the world of congenital heart defects (CHDs). Born with tricuspid atresia, a ventricular septal defect, and an atrial septal defect, Marina's journey from a life-saving C-section to being among the first in Switzerland to undergo a modified-Fontan procedure at just 11 months old is nothing short of miraculous. In our conversation, Marina unfolds her inspiring story and shares her passion for working at atHeart Medical, where she is dedicated to promoting innovative solutions for those with similar heart conditions.Navigating the complexities of living with Atrial Fibrillation (AFib) and congenital heart defects is no small feat. Marina opens up about her personal experiences with rapid heart rates and the profound decision to undergo an ablation. As she contemplates the intricate considerations surrounding pregnancy with a congenital heart condition, we delve into the evolving medical advice she received and the diverse perspectives of healthcare professionals. Marina's story is a testament to the importance of specialized care and the expertise found at top hospitals in Switzerland.From finance to the medical field, Marina's career journey is a testament to aligning work with personal values and health needs. As she shares her transition to atHeart Medical, a startup focused on congenital heart defects, Marina highlights the rewards of working in a supportive environment that truly understands the challenges of living with CHD. Her advocacy extends beyond her professional life, as she continues to inspire others with similar heart conditions to pursue their passions and find purpose in their careers. Marina's resilience shines through as she navigates life's challenges with a positive attitude and a commitment to the CHD community.Helpful Links:atHeart Medical website: https://atheartmedical.comSupport Organizations:Mended Hearts: https://mendedhearts.org(In German)Herznetz: https://www.herznetz.ch/Fontanherzen: https://fontanherzen.ch/Swiss Heart: https://swissheart.ch/Thanks to our newest HUG Patron, Ayrton Beatty and long-standing Patrons: Laura Redfern, Pam Davis, Michael Liben, Nancy Jensen, Alicia Lynch, Deena Barber, Carlee McGuire, Carter & Faye Mayberry, and Frank Jaworski. We appreciate you!Support the showAnna's Buzzsprout Affiliate LinkBaby Blue Sound CollectiveSocial Media Pages:Apple PodcastsFacebookInstagramMeWeTwitterYouTubeWebsite

This week we delve into the world of the single ventricle when we speak with Dr. David Hoganson, Assistant Professor of Surgery at Harvard Medical School about a recent work he co-published with investigators from Boston Children's Hospital on computational fluid dynamic modeling in the planning of the Fontan operation. Single ventricle heterotaxy patients with interrupted IVC are at enhanced risk for the development of pulmonary AVM's due to flow maldistribution to the pulmonary arteries from the hepatic veins in a Fontan. Can a computational fluid dynamic model predict which operative approach would result in the most balanced hepatic venous flow distribution? Can this reduce the incidence of pulmonary AVM's? How well did the models predict the actual pulmonary flow measured after surgery on CMR? Who beyond the heterotaxy patient might benefit from this approach? Dr. Hoganson offers us a peek into the world of personalized surgery in this week's exciting episode.         DOI: 10.1016/j.jacadv.2024.101057

This week we turn back the clocks to re-review a recent research letter from the team at the Harvard Congenital Heart Program about venous insufficiency in the Fontan patient. Why do patients with Fontan circulation develop chronic venous insufficiency and what are the implications of this problem in the Fontan patient? What sort of evaluation should be performed on the Fontan patient presenting with lower extremity venous changes? How worried should the cardiologist be when presented with a Fontan patient with these changes? These are amongst the questions reviewed on this topic with this week's guest, Associate Professor at Baylor University, Dr. Tony Pastor.JACC Adv 2022 Mar, 1 (1) 100002

This week we review a recent paper from last 2023 about outcomes of cardiac transplantation in the adult congenital heart patient (ACHD). Little has been written on this topic until this very robust and large scale report. How do single ventricle ACHD patients fair at transplant and how do they compare to non-ACHD heart transplant recipients? Why might 1 and 3 year outcomes not be a 'fair' method of assessing outcomes in this very high risk patient group? How do HLHS patient outcomes compare with other single ventricles? Are there better ways to measure risk in this patient group and how might the data in this work inform risk stratification and management of failing Fontan patients in whom transplantation is being considered? These are amongst the questions posed this week to the week's expert, Dr Daphne Hsu who is Professor of Pediatrics at the Albert Einstein College of Medicine at The Children's Hospital at Montefiore. https://doi.org/10.1016/j.jacc.2023.06.037For those interested in learning more about Dr. Hsu, take a listen to episode #166 from June, 2021:https://www.spreaker.com/episode/pediheart-podcast-166-a-conversation-with-professor-daphne-hsu--45144274

Noticias Con Café 21/06/2024 La culpa en el Gobierno de Pierluisi es huérfana. La insistencia de Fermín Fontanés de no asumir responsabilidad por el mal trabajo de LUMA. Violencia de Estado y violación de derechos humanos el fracaso de la privatización de energía ante Comité de Descolonización de la ONU. Pierluisi inaugura “obras” con AAA, agencia que nunca ha respondido por los permisos que otorgó para desarrollos de terrenos protegidos en Salinas. El lunes se demolerá la primera de muchas construcciones ilegales. ¡Sintoniza y Comparte! #periodismoindependiente #periodismodigital #puertorico #anairmariveralassen #ferminfontanes #jessikapadilla

Noticias Con Café 19/06/2024 El desempeño de Fermín Fontanés frente a las Alianzas Público Privadas que se supone que fiscalicen los contratos de privatizadores. ¿Será similar al de Luma Energy? El análisis de sus expresiones ayer. Lo que dijo de la contratación para construir una planta de gas metano en PR que negocia en NYC con tres proveedores. Las regalías de los músicos, más allá de la orquesta y de sus dueños. La crisis de energía mata a gente, dicen los portavoces de proveedores de servicios de salud. ¡Sintoniza y Comparte! #periodismoindependiente #periodismodigital #puertorico #rafaelithier #ferminfontanes #anaescobar

This week we review a recent survey study on the topic of junctional rhythm and sinus node dysfunction in the Fontan. How important is this finding in our Fontan patients? When should a patient with a Fontan undergo pacemaker insertion? Is the loss of AV synchrony the more important hemodynamic effect of junctional rhythm or is it chronotropic incompetence? Who should be considered for a possible endocardial, transvenous atrial pacemaker in the Fontan patient? These are amongst the questions posed to this week's guest, noted pediatric electrophysiologist and Professor of Pediatrics at OHSU, Dr. Seshadri Balaji. https://doi.org/10.1007/s00246-023-03296-6

This week we delve into the world of interventional cardiology and the Fontan when we review a recent report from the Children's Hospital of Philadelphia on the use of the "MitraClip" for the treatment of AV valve regurgitation in the congenital heart patient. Who would be a good candidate for this novel approach? What are the steps in planning or consideration of this technique in a congenital heart patient? How durable is this form of repair? These are amongst the many questions reviewed this week with this week's senior author, Professor of Pediatrics at the Children's Hospital of Philadelphia, Dr. Matthew J. Gillespie. DOI: 10.1002/ccd.30935

This week we enter the world of the adult congenital heart patient when we discuss Fontan associated liver disease with an ACHD expert, Dr. Katia Bravo-Jaimes of the Mayo Clinic. In this episode we discuss the role of intrahepatic transcriptomics and how genetic analysis of liver biopsy tissue may provide new insights into the pathophysiology of this disease process. How can differential gene expression in the liver of Fontan patients help to explain why some patients have mild versus others severe fibrosis or even frank cirrhosis? Can these insights provide hope for improved surveillance or therapy for this problem? Dr. Bravo-Jaimes provides the answers this week. https://doi.org/10.1016/j.jacc.2023.12.005

This week we enter the world of the adult congenital heart patient when we discuss Fontan associated liver disease with an ACHD expert, Dr. Katia Bravo-Jaimes of the Mayo Clinic. In this episode we discuss the role of intrahepatic transcriptomics and how genetic analysis of liver biopsy tissue may provide new insights into the pathophysiology of this disease process. How can differential gene expression in the liver of Fontan patients help to explain why some patients have mild versus others severe fibrosis or even frank cirrhosis? Can these insights provide hope for improved surveillance or therapy for this problem? Dr. Bravo-Jaimes provides the answers this week. https://doi.org/10.1016/j.jacc.2023.12.005